Further Retrospect Clinical Study for FDA IND Exemption - Etoposide and Single Nucleotide Polymorphisms (Drugs-SNPs)
This study is ongoing, but not recruiting participants.
Sponsor:
Dr. Han Xu, Clinical Investigator / PD / PI / CEO
Information provided by (Responsible Party):
Dr. Han Xu, Clinical Investigator / PD / PI / CEO, Medicine Invention Design, Inc
ClinicalTrials.gov Identifier:
NCT01064466
First received: February 2, 2010
Last updated: January 31, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |